U.S. markets closed
  • S&P 500

    4,455.48
    +6.50 (+0.15%)
     
  • Dow 30

    34,798.00
    +33.18 (+0.10%)
     
  • Nasdaq

    15,047.70
    -4.54 (-0.03%)
     
  • Russell 2000

    2,248.07
    -10.97 (-0.49%)
     
  • Crude Oil

    73.95
    +0.65 (+0.89%)
     
  • Gold

    1,750.60
    +0.80 (+0.05%)
     
  • Silver

    22.37
    -0.27 (-1.20%)
     
  • EUR/USD

    1.1718
    -0.0029 (-0.25%)
     
  • 10-Yr Bond

    1.4600
    +0.0500 (+3.55%)
     
  • GBP/USD

    1.3681
    -0.0040 (-0.29%)
     
  • USD/JPY

    110.6850
    +0.3840 (+0.35%)
     
  • BTC-USD

    43,308.06
    +748.73 (+1.76%)
     
  • CMC Crypto 200

    1,067.20
    -35.86 (-3.25%)
     
  • FTSE 100

    7,051.48
    -26.87 (-0.38%)
     
  • Nikkei 225

    30,248.81
    +609.41 (+2.06%)
     
  • Oops!
    Something went wrong.
    Please try again later.

FDA aiming to give final approval to Pfizer vaccine by early next month: NY Times

·1 min read
In this article:
  • Oops!
    Something went wrong.
    Please try again later.

 WASHINGTON, Aug 3 (Reuters) - The U.S. Food and Drug Administration is aiming to give full approval for the Pfizer COVID vaccine by early September, the New York Times reported on Tuesday, citing people involved in the effort. 

  The FDA gave emergency use authorization to the Pfizer vaccine late last year. Full approval by the FDA could push more Americans to get the COVID-19 vaccine as it might reduce their fears about the safety of the shot. 

  The agency's unofficial deadline for the approval is the Sept. 6 Labor Day holiday, the Times said. 

  President Joe Biden said last week he expected the FDA to make the decision by early fall. 

  The FDA said in a statement on Friday that the agency is moving as rapidly as possible on the Pfizer application. 

  The spread of the highly contagious coronavirus Delta variant has fueled a new surge in infections, with the CDC reporting rising numbers of cases in nearly 90% of U.S. jurisdictions. 

  (Reporting by Eric Beech; Editing by Sandra Maler and Stephen Coates) 

(Adds details and background)